Rapamycin has been trending on social media, where biohackers such as Dr. Peter Attia and Bryan Johnson tout it as the “gold standard” for people seeking to live a longer, healthier life. Rapamycin is ...
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Animal studies say rapamycin can slow aging – but does it work in humans? A new review finds the evidence for the off-label, low-dose use of the drug in healthy adults is thin, inconsistent, and far ...
A clinical trial is starting to test a drug taken by many so-called longevity enthusiasts. NPR's Allison Aubrey explains why a dentist is leading the research. ALLISON AUBREY, BYLINE: A few years back ...
Rapamycin and its analogs are clinically important macrolide compounds produced by Streptomyces hygroscopicus. They exhibit antifungal, immunosuppressive, antitumor, neuroprotective and antiaging ...
The hype around the off-label use of the immunosuppressant rapamycin to prevent aging and increase longevity could be unfounded. This is the warning of researchers who have critically explored ...
Rapamycin essentially signals to mTOR to send out the message to slow down and do some clean-up (autophagy). This makes cells better at responding to stress and presses pause on unchecked cell growth, ...
Most current medicines are derived from naturally occurring small molecules. Yet the lack of a systematic method for producing diverse nature-inspired small molecules has prevented the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback